Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Based on whether the matched random number was odd or even, patients were allocated to either the study group or the control group, ensuring an equal probability of assignment to each group
Contact your provider if the wearing-off effect persists beyond six to eight weeks at the same dose
For some people who are no longer breastfeeding and have medical clearance, a GLP-1 may be appropriate later on, but there is no universal best option immediately after birth
Monitor for: Gastrointestinal symptoms: Nausea or vomiting (occurring in approximately 1520% of patients at therapeutic doses per FDA labeling) Abdominal pain or cramping Diarrhea or constipation Loss of appetite or early satiety Bloating or abdominal distension Hypoglycemia indicators (particularly if you take other diabetes medications): Trembling, shakiness, or sweating Rapid heartbeat or palpitations Dizziness, lightheadedness, or confusion Hunger or irritability Headache or blurred vision Injection site reactions: Bruising, swelling, or hematoma formation Persistent pain or tenderness Redness or warmth suggesting inflammation Hardness or nodule formation under the skin Semaglutide's mechanism involves glucose-dependent insulin secretion, meaning hypoglycemia risk is generally low when used as monotherapy
K., Nicklas, B
